CRM vs MA: Which Is the Better Buy?

Side-by-side comparison of Salesforce, Inc. and Mastercard Incorporated โ€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-09-22.
Salesforce, Inc. ยท Technology
$236.42
+11.6% upside to fair value
Med Conviction Grade B High Quality
VS
Mastercard Incorporated ยท Financial Services
$574.42
+25.0% upside to fair value
Med Conviction Grade A- High Quality
QuantHub Verdict
MA has more upside to fair value (+25.0%). These are model outputs โ€” not personalized investment advice. See all research โ†’
Valuation & Fundamentals
Metric CRM MA
Current Price $236.42 $574.42
Fair Value Estimate $263.88 $718.00
Upside to Fair Value +11.6% +25.0%
Market Cap $193.6B $503.8B
Forward P/E โ€” โ€”
EV / EBITDA 14.4x 23.4x
Price / Sales 4.4x 14.4x
Price / FCF 12.8x 30.8x
Revenue Growth YoY +10.8% +14.1%
Gross Margin 77.3% 100%
Operating Margin 21.4% 59.8%
Return on Equity 20.2% 232.5%
Dividend Yield 0.73% 0.59%
FCF Yield 7.82% 3.25%
Analyst Consensus Buy Strong Buy
Investment Thesis
CRM โ€” Salesforce, Inc.
Salesforce is the leading enterprise customer relationship management platform, spanning Sales, Service, Platform, Marketing, Commerce, Tableau, MuleSoft, and Slack under the Customer 360 umbrella, with 83,334 employees and a business that converts $53.65 of revenue per share into $18.48 of free cash flow per share. Business quality is high: TTM gross margin of 77.3%, TTM operating margin of 21.4โ€ฆ
MA โ€” Mastercard Incorporated
Mastercard operates a global payments network that connects issuers, acquirers, merchants and consumers across more than 200 countries and territories, monetizing payment volumes, cross-border activity and higher-growth value-added services. Business quality is high because its two-sided network, trusted authorization-clearing-settlement infrastructure, brand, security capabilities and broad acceโ€ฆ
Accumulation Zones
Metric CRM MA
Zone Low $197.91 $538.50
Zone High $224.30 $610.30
In Buy Zone? No Yes
โ† CRM Research    MA Research โ†’    All Research